+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Phase 2
Age: 18Years +
All Genders
ID07807111

Evaluating Safety, Tolerability, and Efficacy of Single Intravitreal Injection of SPVN20 Gene Therapy in Adults With Advanced Rod-Cone Dystrophy

Led by SparingVision · Updated on 2026-09-08

27

Participants Needed

3

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety, tolerability, and effectiveness of a gene therapy called SPVN20 in adults with advanced Rod-Cone Dystrophy, a rare eye condition affecting vision. This open-label, multi-center study is a Phase IIIa trial designed to test escalating doses of SPVN20 delivered through a single injection into the eye. The trial aims to understand how well the treatment works and how safe it is for patients with this advanced retinal disease. Participants will receive a single intravitreal injection of SPVN20 in one eye. They will be assigned sequentially to one of three groups receiving low, medium, or high doses of SPVN20. Each group will include nine participants. This first-in-human study involves careful monitoring of participants over time to observe the effects of different doses and to find the best balance of safety and potential benefit. Throughout the study, participants will be followed for five years after the injection. They will undergo regular eye exams, vision tests including best corrected visual acuity and full-field stimulus threshold tests, and monitoring for any side effects or eye safety concerns. An independent committee will review safety data to ensure participant well-being. The long-term follow-up will help researchers gather detailed information about the gene therapys impact and any lasting effects.

CONDITIONS

Brief Title

Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of Gene Therapy (SPVN20) in Subjects With Rod-Cone Dystrophy

Research Team

M

Medical Director

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here